在心脏里亚诺丁受体通道病变中存在不同的分子机制
Yadan Zhang1, Monika Seidel1, Camille Rabesahala de Meritens1
1Swansea University Medical School, Institute of Life Science, Swansea, United Kingdom.
Frontiers in molecular biosciences
|January 8, 2025
概括
心脏里亚诺丁受体 (RyR2) 的突变导致CPVT. 独特的RyR2 N端域 (NTD) 突变破坏了NTD-NTD或NTD-CSol相互作用,导致处理和心律失常的改变.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 生物物理学的生物物理.
背景情况:
- 心脏里亚诺丁受体 (RyR2) 的突变是catecholaminergic多态心室性心跳动 (CPVT) 的主要原因.
- 了解 RyR2 突变的分子机制对于开发向疗法至关重要.
- RyR2的N端域 (NTD) 在道功能和调节中起着至关重要的作用.
研究的目的:
- 调查RyR2 N端域 (NTD) 中CPVT相关突变的分子机制.
- 为了比较影响不同NTD接口的突变的结构和功能影响.
主要方法:
- 高分辨率的RyR2结构分析以确定突变位置.
- 化学交叉链接和共免疫沉试验用于评估蛋白质相互作用.
- 单细胞 (Ca2+) 图像检测,以评估道功能和处理.
主要成果:
- R169L突变破坏了NTD四重化,影响了RyR2通道功能,增加了自发的Ca2+过渡体.
- A77T突变增强了NTD-CSol相互作用,导致自发Ca2+过渡的增加,但Ca2+过渡幅度和持续时间发生变化.
- 突变G357S/R407I对NTD四重化或NTD-CSol相互作用的影响很小,而RyR2G357S细胞表现出正常的Ca2+处理.
结论:
- 与CPVT相关的RyR2 NTD突变可能来自不同的分子机制,包括NTD-NTD相互作用的破坏或改变的NTD-CSol相互作用.
- A77T突变代表了通过加强NTD-CSol相互作用来获得RyR2功能的新机制.
- 这些发现凸显了RyR2 NTD在心律失常中的复杂结构和功能作用.
相关概念视频
01:28Mechanism of Cardiac Arrhythmias
886
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
886
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
450
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
450
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
452
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
452
01:30Cardiac Action Potential
952
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
952
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
900
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
900